Univariate analysis for the association between organ-based toxicities grade ≥3 and risk of event and death
. | EFS . | OS . | ||
---|---|---|---|---|
HR (95% CI) . | P . | HR (95% CI) . | P . | |
Cardiovascular-based complication | 1.27 (0.55-2.91) | .57 | 1.15 (0.38-3.42) | .80 |
Hematologic-based complication | 2.24 (0.91-5.49) | .08 | 1.35 (0.53-3.44) | .54 |
Metabolic-based complication | 1.29 (0.66-2.52) | .46 | 1.62 (0.66-3.96) | .29 |
Neurologic-based complication | 1.14 (0.51-2.52) | .75 | 1.66 (0.64-4.32) | .30 |
Pulmonary-based complication | 2.28 (0.94-5.56) | .07 | 2.92 (1.06-8.02) | .04 |
Infection-based complication | 1.14 (0.53-2.47) | .74 | 1.57 (0.62-3.93) | .34 |
CRS | 1.95 (0.80-4.72) | .14 | 2.43 (0.81-7.29) | .11 |
. | EFS . | OS . | ||
---|---|---|---|---|
HR (95% CI) . | P . | HR (95% CI) . | P . | |
Cardiovascular-based complication | 1.27 (0.55-2.91) | .57 | 1.15 (0.38-3.42) | .80 |
Hematologic-based complication | 2.24 (0.91-5.49) | .08 | 1.35 (0.53-3.44) | .54 |
Metabolic-based complication | 1.29 (0.66-2.52) | .46 | 1.62 (0.66-3.96) | .29 |
Neurologic-based complication | 1.14 (0.51-2.52) | .75 | 1.66 (0.64-4.32) | .30 |
Pulmonary-based complication | 2.28 (0.94-5.56) | .07 | 2.92 (1.06-8.02) | .04 |
Infection-based complication | 1.14 (0.53-2.47) | .74 | 1.57 (0.62-3.93) | .34 |
CRS | 1.95 (0.80-4.72) | .14 | 2.43 (0.81-7.29) | .11 |